C8γ Activators
C8γ activators are a diverse array of chemical compounds that directly or indirectly promote the functional activity of the C8γ protein. Forskolin, a potent stimulator of adenylate cyclase, elevates intracellular cAMP, thereby activating PKA, which is known to phosphorylate target proteins including C8γ. This phosphorylation enhances the activity of C8γ, which is crucial for its role in the complement cascade. Similarly, dibutyryl cAMP and 8-Br-cAMP, both stable cAMP analogs, bypass cellular regulatory mechanisms to sustain PKA activation, thus potentially amplifying C8γ function. The activation of PKC by PMA could also lead to enhanced C8γ activity through phosphorylation events that promote its incorporation into the membrane attack complex, which is a key component of the complement system's defense mechanism.
Calcium ionophores like Ionomycin and A23187 raise intracellular calcium levels, activating calcium-dependent signaling pathways that could indirectly bolster the activity of C8γ within the complement pathway. Arachidonic acid, through its metabolites, can influence inflammatory processes and complement activation, potentially aiding in the optimal function of C8γ. Moreover, GTPγS and Aluminum fluoride (AlF4-) target G-proteins, and by doing so, they may modulate intracellular signaling cascades in such a way that could lead to enhanced C8γ activity. These G-proteins play a role in various cellular processes, including the regulation of the complement system, and their activation can result in the downstream effects that promote the assembly and function of the complement complex, where C8γ is an integral component. Isoproterenol, a beta-adrenergic receptor agonist, increases intracellular levels of cAMP, thus triggering PKA activation, which could, in turn, facilitate the phosphorylation and functional enhancement of C8γ in its role in the complement pathway. UTPγS, a stable analog of UTP, activates P2Y receptors, which can influence a range of signaling pathways that may ultimately contribute to the regulation and activation of C8γ.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, increasing cAMP levels in cells. Elevated cAMP activates protein kinase A (PKA), which can phosphorylate target proteins including C8γ, thereby enhancing its activity within the complement system. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). PKC activation can lead to phosphorylation of components within the complement pathway, potentially increasing the functional activity of C8γ by promoting its integration into the C5b-9 complex. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, raising intracellular calcium levels. Elevated Ca2+ can activate various calcium-dependent enzymes, indirectly enhancing the activity of C8γ by modulating the assembly of the complement membrane attack complex. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that increases intracellular Ca2+ concentration, similarly to Ionomycin. This can activate downstream calcium-dependent pathways that bolster C8γ activity during the formation of the membrane attack complex. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
Arachidonic acid serves as a precursor for eicosanoids, which can modulate inflammation and complement activation. Metabolites of arachidonic acid might enhance C8γ function by facilitating its interaction with other complement components. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP is a cell-permeable cAMP analog. It activates PKA, leading to enhanced phosphorylation and potential activation of C8γ, thereby contributing to its role in the complement system. | ||||||
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $465.00 | ||
GTPγS is a non-hydrolyzable GTP analog that can activate G-proteins. Persistent G-protein activation may indirectly enhance C8γ function by modulating signaling pathways involved in the regulation of the complement system. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that can increase cAMP levels through G-protein coupled receptor signaling, indirectly leading to PKA activation and subsequent enhancement of C8γ activity. | ||||||
Aluminum Fluoride | 7784-18-1 | sc-291881 sc-291881A | 10 g 50 g | $67.00 $250.00 | ||
AlF4- acts as an activator of heterotrimeric G-proteins, mimicking the γ-phosphate of GTP. This activation can lead to downstream effects that enhance the functional activity of C8γ in the complement system. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Br-cAMP is a cAMP analog resistant to degradation, which can activate PKA. This sustained PKA activation may enhance C8γ activity by facilitating its role in the complement cascade. | ||||||